NANoREG D5 07

NANoREG D1.02 DR Regulatory data gaps and research needs

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d102-dr-regulatory-data-gaps-and-research-needs

NANoREG D5 06 DR Identification and optimization of the most suitable in vitro methodology

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-06-dr-identification-and-optimization-of-most-suitable-in-vitro-methodology 

SOPs available in deliverable:

• SOP 01 LAL Assay for Nanoparticles
• SOP 02 LDH assay
• SOP 03 Reaction Oxygen Species Detection
• SOP 04 Human Lung Cell transformation assay. Long term chronic experiment
• SOP 05 Apoptosis/Necrosis Analysis
• SOP 06 Production of pro-inflammatory cytokines

NANoREG D5.07 SOP 06 HEL16T008 AlamarBlue Assay

Acesse:

https://www.rivm.nl/documenten/nanoreg-d507-sop-06-hel16t008-alamarblue-assay 

NANoREG D1 08 DR Case study summary report including feasibility check of the proposed answers

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d1-08-dr-case-study-summary-report-including-feasibility-check-of-proposed

NANoREG D1.12 Prospective tools

Acesse:

https://www.rivm.nl/documenten/nanoreg-d112-prospective-tools

Work book and toolbox available via:

http://data.europa.eu/89h/jrc-nano-ehs-ring-nanoreg-tb

NANoREG D1.12 ToolBox workbook

https://www.rivm.nl/documenten/nanoreg-d112-toolbox-workbook

NANoREG D1.12 Prospective tools

https://www.rivm.nl/documenten/nanoreg-d112-prospective-tools

Work book and toolbox available via:

http://data.europa.eu/89h/jrc-nano-ehs-ring-nanoreg-tb

NANoREG D5.07 SOP 05 Viability protocol by using a Cell Counter

Acesse:

https://www.rivm.nl/documenten/nanoreg-d507-sop-05-viability-protocol-by-using-a-cell-counter